70 related articles for article (PubMed ID: 15574789)
21. Kruppel-like factor 6 in the progression and prognosis of malignant melanoma.
Cai D; Zhao J; Sun Q
J Int Med Res; 2014 Feb; 42(1):184-90. PubMed ID: 24366496
[TBL] [Abstract][Full Text] [Related]
22. Stage-specific prognostic biomarkers in melanoma.
Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y
Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655
[TBL] [Abstract][Full Text] [Related]
23. Nucleolin protein expression in cutaneous melanocytic lesions.
Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma.
Masugi Y; Tanese K; Emoto K; Yamazaki K; Effendi K; Funakoshi T; Mori M; Sakamoto M
Pathol Int; 2015 Dec; 65(12):627-34. PubMed ID: 26374196
[TBL] [Abstract][Full Text] [Related]
25. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
[TBL] [Abstract][Full Text] [Related]
27. Maspin expression in the invasive margin of primary melanomas may reflect an aggressive tumor phenotype.
Pföhler C; Knöpflen T; Körner R; Vogt T; Rösch A; Müller CS
J Dtsch Dermatol Ges; 2013 Oct; 11(10):993-9. PubMed ID: 23848940
[TBL] [Abstract][Full Text] [Related]
28. Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.
Berger AJ; Davis DW; Tellez C; Prieto VG; Gershenwald JE; Johnson MM; Rimm DL; Bar-Eli M
Cancer Res; 2005 Dec; 65(23):11185-92. PubMed ID: 16322269
[TBL] [Abstract][Full Text] [Related]
29. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors.
Gelsleichter L; Gown AM; Zarbo RJ; Wang E; Coltrera MD
Mod Pathol; 1995 Jun; 8(5):530-5. PubMed ID: 7675773
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
Bhandaru M; Martinka M; McElwee KJ; Rotte A
PLoS One; 2015; 10(8):e0134678. PubMed ID: 26275218
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of Apaf-1 with progression of melanoma.
Mustika R; Budiyanto A; Nishigori C; Ichihashi M; Ueda M
Pigment Cell Res; 2005 Feb; 18(1):59-62. PubMed ID: 15649154
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.
Poremba C; Yandell DW; Metze D; Kamanabrou D; Böcker W; Dockhorn-Dworniczak B
Oncol Res; 1995; 7(7-8):331-9. PubMed ID: 8747596
[TBL] [Abstract][Full Text] [Related]
34. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
35. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
36. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
37. Comparative histopathology of grey-horse-melanoma and human malignant melanoma.
Seltenhammer MH; Heere-Ress E; Brandt S; Druml T; Jansen B; Pehamberger H; Niebauer GW
Pigment Cell Res; 2004 Dec; 17(6):674-81. PubMed ID: 15541026
[TBL] [Abstract][Full Text] [Related]
38. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
40. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
Mihic-Probst D; Kuster A; Kilgus S; Bode-Lesniewska B; Ingold-Heppner B; Leung C; Storz M; Seifert B; Marino S; Schraml P; Dummer R; Moch H
Int J Cancer; 2007 Oct; 121(8):1764-70. PubMed ID: 17597110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]